Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treating critically ill patients with intravenous ibuprofen

Treating critically ill patients with intravenous ibuprofen

US Patent 9649284 · Granted May 16, 2017

Estimated economic value: $953,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods of treating cardiac fibrosis with ifetroban2024
Injectable ibuprofen formulation2023
Thromboxane receptor antagonists in AERD/asthma2023
Compositions and methods of treating cardiac fibrosis with ifetroban2021
Compositions and methods of treating cardiac fibrosis with ifetroban2020
Compositions and methods of treating muscular dystrophy with thromboxane-A2 rece2019
Compositions and methods of treating cardiac fibrosis with ifetroban2019
Compositions and methods of treating muscular dystrophy with thromboxane-A2 rece2018
Compositions and methods of treating cardiac fibrosis with ifetroban2018
Treating critically ill patients with intravenous ibuprofen2018
Treating critically ill patients with intravenous ibuprofen2018
Stabilized statin formulations2017